Dolby Laboratories (NYSE:DLB) Given “Buy” Rating at Rosenblatt Securities

Rosenblatt Securities reiterated their buy rating on shares of Dolby Laboratories (NYSE:DLB) in a research report report published on Friday,Benzinga reports. The firm currently has a $85.00 target price on the electronics maker’s stock.

A number of other equities analysts have also weighed in on DLB. Barrington Research cut their price objective on shares of Dolby Laboratories from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday, January 26th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a report on Monday, December 29th. Finally, Wall Street Zen upgraded Dolby Laboratories from a “hold” rating to a “buy” rating in a report on Monday, January 5th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $90.75.

Dolby Laboratories Stock Up 1.8%

NYSE DLB opened at $64.19 on Friday. The stock has a market cap of $6.13 billion, a price-to-earnings ratio of 25.88 and a beta of 0.88. Dolby Laboratories has a fifty-two week low of $60.14 and a fifty-two week high of $85.49. The business has a fifty day moving average of $65.07 and a 200-day moving average of $68.88.

Dolby Laboratories (NYSE:DLB) last posted its quarterly earnings data on Thursday, January 29th. The electronics maker reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.99 by $0.07. The firm had revenue of $346.71 million during the quarter, compared to analysts’ expectations of $341.26 million. Dolby Laboratories had a return on equity of 11.49% and a net margin of 17.97%.The firm’s quarterly revenue was down 2.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.14 EPS. As a group, analysts anticipate that Dolby Laboratories will post 2.94 EPS for the current year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 18th. Stockholders of record on Tuesday, February 10th will be paid a dividend of $0.36 per share. The ex-dividend date of this dividend is Tuesday, February 10th. This represents a $1.44 annualized dividend and a dividend yield of 2.2%. Dolby Laboratories’s payout ratio is currently 54.75%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was sold at an average price of $65.55, for a total transaction of $196,650.00. Following the completion of the sale, the senior vice president directly owned 67,435 shares in the company, valued at $4,420,364.25. This represents a 4.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Mark Andrew Sherman sold 9,109 shares of Dolby Laboratories stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $66.73, for a total value of $607,843.57. Following the completion of the transaction, the executive vice president directly owned 73,054 shares in the company, valued at $4,874,893.42. This represents a 11.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 137,120 shares of company stock valued at $9,184,809. Corporate insiders own 37.93% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of DLB. New York State Teachers Retirement System grew its stake in Dolby Laboratories by 16.8% during the fourth quarter. New York State Teachers Retirement System now owns 14,817 shares of the electronics maker’s stock worth $952,000 after buying an additional 2,129 shares during the period. State of New Jersey Common Pension Fund D raised its stake in shares of Dolby Laboratories by 13.7% in the 4th quarter. State of New Jersey Common Pension Fund D now owns 33,203 shares of the electronics maker’s stock valued at $2,132,000 after acquiring an additional 4,001 shares during the period. Cardinal Capital Management lifted its holdings in shares of Dolby Laboratories by 1.6% during the 4th quarter. Cardinal Capital Management now owns 45,658 shares of the electronics maker’s stock valued at $2,932,000 after acquiring an additional 715 shares in the last quarter. Vest Financial LLC boosted its position in Dolby Laboratories by 56.0% during the 4th quarter. Vest Financial LLC now owns 85,070 shares of the electronics maker’s stock worth $5,463,000 after purchasing an additional 30,532 shares during the period. Finally, M&T Bank Corp increased its holdings in Dolby Laboratories by 40.2% in the 4th quarter. M&T Bank Corp now owns 19,964 shares of the electronics maker’s stock valued at $1,283,000 after purchasing an additional 5,722 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Key Stories Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Company raised FY?2026 and Q2 guidance well above Street estimates (FY EPS 4.30–4.45 vs. consensus ~3.79; Q2 EPS 1.29–1.44). The stronger outlook is the main catalyst supporting the stock today.
• Positive Sentiment: Dolby announced a quarterly dividend of $0.36 per share (yield ~2.3%), which can attract income-oriented investors and support the share price around the ex?dividend date.
• Positive Sentiment: Rosenblatt reaffirmed a “Buy” rating with an $85 price target, adding analyst support and upside narrative for investors. Benzinga
• Neutral Sentiment: Q1 results beat consensus on EPS ($1.06 vs. ~$0.99) and revenue (~$346.7M vs. ~341M), indicating operational resilience even as some metrics softened. PR Newswire
• Negative Sentiment: Revenue and EPS were down year-over-year (revenue down ~2.8%), driven by weaker licensing, which triggered an after?hours selloff after the print and remains a near-term risk. Zacks
• Negative Sentiment: Operational and cash-flow pressures were noted (operating profit and net income declined; temporary negative operating cash flow and higher capex flagged by third?party summaries), which could weigh on near?term margins and investor sentiment. Quiver Quant

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.